首页 › 基金 › NEXTBio Capital Management LP › BIOA

NEXTBio Capital Management LP 对 BIOA 的持仓历史

BIOAGE LABS INC · 医疗保健

NEXTBio Capital Management LP 在 Q2 2026 的 13F 申报中披露持有 BIOA(BIOAGE LABS INC)100,732 股,市值约 US$2.5M,约占其申报组合的 1.14%,在其申报持仓中市值排名第 19 位。 NEXTBio Capital Management LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)100.73K 股
申报持仓市值$2.47M
组合权重1.14%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

NEXTBio Capital Management LP 对 BIOA 的持仓演变

NEXTBio Capital Management LP 于 Q2 2026 首次披露 BIOA 持仓:100,732 股(约 US$2.5M)。

逐季持仓明细

季度股数金额变化
Q2 2026 100.73K $2.47M 新进

关于 BIOA 与 13F 数据

BIOA(BIOAGE LABS INC)属于医疗保健行业。我们追踪的基金中还有 78 只申报持有 BIOA,申报仓位最大的包括:a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BIOA 的基金

查看 BIOA 的全部基金持有人 →

常见问题

How long has NEXTBio Capital Management LP held BIOA?

NEXTBio Capital Management LP has disclosed BIOA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is NEXTBio Capital Management LP's current position in BIOA?

As of Q2 2026, NEXTBio Capital Management LP holds 100.73K shares of BIOA (BIOAGE LABS INC), valued at $2.47M, representing 1.14% of its reported portfolio and ranking #19.

Has NEXTBio Capital Management LP been buying or selling BIOA?

In the latest 13F filing (Q2 2026), NEXTBio Capital Management LP newly opened its position in BIOA.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.